Study Comparing Cortical Function and Dysfunction Tests in Low Back Pain
NCT ID: NCT00924495
Last Updated: 2013-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2009-06-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
State vs. Trait Alterations in Low Back Pain
NCT06412484
Photobiomodulation Therapy on Inflammatory Mediators on Low Back Pain
NCT03859505
Structural White and Gray Matter Correlates of Impaired Muscle Control and Deficient Pain Processing
NCT06143319
Regulation of Emotions and Coping Behaviour in Patients With Chronic Recurrent Low Back Pain
NCT02251444
Use of Biofeedback Training to Correct Abnormal Neuromechanical Pattern in Chronic Low Back Pain Patients
NCT02239289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cortical function
Activity/inhibition of the cortex
transcranial magnetic stimulation
rTMS therapy daily for two weeks, five times per week each lasting for half an hour
Cortical regulation
transcranial magnetic stimulation
rTMS therapy daily for two weeks, five times per week each lasting for half an hour
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial magnetic stimulation
rTMS therapy daily for two weeks, five times per week each lasting for half an hour
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male gender
* age 25-50 yrs
* average pain during last week 4-8/10 by VAS
* Oswestry disability index 20-80 %
Exclusion Criteria
* rheumatic disease, marked spondylolysis and -olisthesis, other diseases that markedly reduce physical or psychological performance, history of epilepsy, history of taking epileptic or strong opioid drugs
25 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kuopio University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
olavi airaksinen
MD, PhD Ass Proff, Head of the Department of Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marja T Kilpiäinen, MD
Role: PRINCIPAL_INVESTIGATOR
Kuopio University Hospital
Markku Kankaanpää, MD,PhD
Role: STUDY_DIRECTOR
Tampere University Hospital
Olavi Airaksinen, MD, PhD
Role: STUDY_CHAIR
Kuopio University Hospital
Timo Miettinen, MD,PhD
Role: STUDY_CHAIR
Kuopio University Hospital
Eeva Leino, MD,PhD
Role: STUDY_CHAIR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kuopio University Hospital
Kuopio, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH5960429
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.